Category: Market News

Seeing Machines (LSE:SEE) delivered a sharp increase in automotive production volumes during the third quarter of FY2026, with more than 1.28 million vehicles equipped with its driver and occupant monitoring systems. The figure represented growth of 122% quarter on quarter and 259% year on year.

The strong performance lifted the company’s global installed vehicle base above 6.1 million units and pushed third-quarter automotive royalty revenue beyond the total generated during the first half of the fiscal year.

Regulatory changes drive adoption of driver monitoring systems

Management said the acceleration reflects growing industry adoption ahead of Europe’s incoming vehicle safety regulations scheduled for July 2026, which are expected to increase demand for Driver Monitoring Systems (DMS).

The company believes the latest quarter represents a turning point toward more stable and structurally higher production volumes as vehicle manufacturers expand deployment of monitoring technology across European automotive platforms.

Operating leverage and profitability targets come into focus

Seeing Machines said the increase in automotive royalties is improving operational leverage and is expected to support positive adjusted EBITDA performance for both the third quarter and the second half of the fiscal year.

Within the company’s Guardian aftermarket division for commercial fleets, hardware sales remained uneven. However, annual recurring revenue increased 5% quarter on quarter to $14.7 million as a larger proportion of installed units became connected to monitoring services.

Management said the growth in recurring revenue improves visibility and supports the expansion of a higher-margin service business.

Strong growth offset by ongoing profitability and cash flow concerns

Despite rapid revenue growth, the company’s broader outlook remains constrained by weak profitability and continued pressure on cash flow generation.

Technical indicators remain supportive, with the share price trading above major moving averages and the MACD indicator remaining positive. However, overbought RSI readings suggest some potential for near-term volatility.

Valuation metrics also remain limited by the company’s loss-making position and the absence of a dividend yield.

More about Seeing Machines

Seeing Machines Limited is an AIM-listed technology company headquartered in Australia that develops AI-powered operator monitoring and computer vision systems designed to improve transport safety. Its driver and occupant monitoring technologies are used across automotive, commercial fleet, off-road and aviation markets through partnerships spanning Australia, the United States, Europe and Asia.

The company’s systems monitor driver attention and cognitive state in real time using embedded sensors and optics, supporting the growing adoption of Driver Monitoring Systems mandated by safety regulators. Seeing Machines generates revenue through automotive production royalties and its Guardian aftermarket fleet monitoring platform, which includes recurring subscription-based services.

Jubilee Metals Group (LSE:JLP) reported a 28.7% rise in total saleable copper production to 2,177 tonnes for the nine months ended 31 March 2026, supported by a significant increase in output from its Roan operations and stronger cathode production at the Sable Refinery.

The company also highlighted a strong operational safety record, maintaining a zero lost-time injury frequency rate during the period.

Roan expansion expected to unlock further production growth

Commissioning of the expanded dewatering facility at Roan is nearing completion and is expected to release an additional fine concentrate stream that could materially increase copper cathode production.

Jubilee said the Roan concentrator is currently operating at roughly 30,000 tonnes per month, with capacity potentially rising above 40,000 tonnes once seasonal rainfall eases and the upgraded dewatering system becomes fully operational.

The progress supports the company’s strategy of building a larger and more integrated copper processing business in Zambia.

Molefe Mine ramp-up supports integrated mine-to-metals strategy

At the Molefe Mine, Jubilee has accelerated pre-stripping activities and pit integration work as part of plans to expand ore supply to the Sable Refinery from mid-2026 onwards.

Approximately 250,000 tonnes of pre-stripping material were removed during April, while quarterly ore deliveries are targeted to increase from around 12,000 tonnes to more than 30,000 tonnes over time.

Management believes the expansion will improve both feed quality and production volumes, strengthening the company’s transition toward a scalable mine-to-metals copper producer with a growing resource base.

Financial pressures and operational uncertainty continue to weigh on outlook

Despite operational progress, Jubilee’s broader outlook remains constrained by a sharp deterioration in recent financial performance, including falling revenue, weaker profitability and negative free cash flow.

Management noted that ongoing disposal initiatives and operational improvements in Zambia could help reduce risk exposure, although deferred production guidance and continuing financing and execution uncertainties continue to weigh on sentiment.

Technical indicators and valuation metrics also remain relatively weak due to loss-making earnings and softer market momentum.

More about Jubilee Metals Group

Jubilee Metals Group is an integrated copper producer and resource developer operating primarily in Zambia. The company processes third-party copper feedstock through its Roan concentrator and Sable Refinery while also developing its own mining operations through the Molefe Mine. Jubilee’s long-term strategy is focused on creating a scalable, resource-backed mine-to-metals copper production platform in the region.

Next plc (LSE:NXT) reported first-quarter full-price sales growth of 6.2%, comfortably ahead of its previous forecast of 4%, as strong early-season demand and continued momentum in online and international operations offset weaker performance from UK retail stores.

The better-than-expected trading added an estimated £8 million to profits, leading the retailer to raise its full-year profit guidance to £1.218 billion. Despite the upgrade, the company left its overall sales outlook unchanged, warning that tougher comparisons later in the year could slow growth.

Online and international channels continue to drive momentum

The group highlighted robust performance across its online platform and international business, while UK store sales remained under pressure. Management noted that future growth rates may moderate as the company laps unusually warm weather conditions seen last year as well as prior one-off gains from European aggregator sales.

Even so, the company said underlying demand trends remain healthy across key product categories and overseas markets.

Middle East disruption creates £47 million cost headwind

Next also outlined the financial impact of ongoing conflict in the Middle East, estimating that freight, fuel and energy costs will increase by approximately £47 million during the current year.

The retailer said these additional expenses would be fully offset through a combination of overseas price increases, currency benefits, operational efficiencies and margin improvements. Importantly, the company stated that no further UK price rises are planned beyond those already announced.

Share buybacks and shareholder returns remain a priority

The company reaffirmed its £510 million share buyback programme and disclosed that £196 million worth of shares has already been repurchased.

Management also indicated that any excess capital not allocated toward buybacks would likely be returned to shareholders through special distributions, underlining confidence in the group’s cash generation and earnings trajectory.

Strong fundamentals offset weaker short-term technical signals

Next’s outlook continues to be supported by strong profitability, resilient margins, improving leverage and robust cash flow generation. Valuation metrics also remain favourable, helped by a reasonable price-to-earnings ratio and an attractive dividend yield.

However, near-term technical indicators remain weaker, with the shares trading below key moving averages and the MACD indicator remaining negative.

More about Next plc

Next plc is a UK-based retailer specialising in fashion, homeware and related products through a combination of online platforms, physical stores and financial services operations. The group sells both own-brand and third-party products across domestic and international markets, with a growing presence through online aggregators and distribution partnerships, particularly in Europe and the Middle East.

Altona Rare Earths (LSE:REE) has entered into a flexible growth capital agreement worth up to £2 million with Zeus Capital to support development activities at its Monte Muambe project and broader diversification strategy.

The funding arrangement allows the company to access capital in four separate tranches through share issuances priced at prevailing market levels. Management said the structure includes measures designed to reduce dilution and help protect shareholder value.

Initial share issue supports rare earth and fluorspar workstreams

As part of the first tranche, Altona has issued 12 million new shares, representing approximately 2.62% of the enlarged share capital. Following the issue, the company’s total voting rights now stand at 457,666,113 shares.

Funds raised through the facility will be directed toward several ongoing development programmes, including a fluorspar scoping study, gallium metallurgical testing, heavy rare earth exploration work and general working capital requirements.

Monte Muambe strategy focused on advancing commercial milestones

The financing is intended to help accelerate progress at the Monte Muambe project as Altona works to convert recent resource estimates into more advanced development milestones.

The company is continuing to evaluate opportunities linked to rare earth elements, fluorspar production and potential gallium recovery, positioning the project to serve growing demand from clean energy, defence and high-technology supply chains.

Financial challenges offset partly by stronger technical momentum

Altona’s outlook remains constrained by weak underlying financial metrics, including the absence of revenue, ongoing losses, continued cash burn and increasing leverage.

However, technical trading indicators have recently improved, with the share price moving above key moving averages and the MACD indicator turning positive. Valuation support remains limited due to negative earnings and the lack of dividend payments.

More about Altona Rare Earths

Altona Rare Earths is a London Main Market-listed exploration and development company focused on critical raw materials projects across Africa. Its flagship Monte Muambe project in Mozambique contains rare earths, fluorspar and gallium resources, while additional assets such as the Sesana Copper-Silver Project in Botswana support a broader strategy targeting commodities linked to clean energy and advanced industrial technologies.

The company has already advanced Monte Muambe through a maiden JORC resource estimate, the granting of a 25-year mining licence and prefeasibility work supported by U.S. grant funding. It is also pursuing opportunities for near-term fluorspar production and potential gallium by-product recovery.

Ascent Resources plc (LSE:AST), the London-listed onshore oil and gas producer focused on U.S. operations, said the arbitration process relating to its Energy Charter Treaty claim against the Republic of Slovenia is approaching conclusion, with a tribunal decision expected in June.

The dispute relates to the company’s historic investments in Slovenia, which remain part of its legacy international portfolio despite its strategic focus on U.S. energy assets.

Arbitration outcome could carry financial and strategic significance

Management indicated that the forthcoming ruling may have important financial and operational implications for the company. A favourable outcome could influence Ascent’s balance sheet position, shape its future approach to international investments and affect broader investor sentiment toward the business.

The case is being pursued under international investment protection frameworks and remains a key non-operational focus for the company alongside its ongoing hydrocarbon activities in the United States.

Financial weakness and negative technical indicators weigh on outlook

Ascent’s broader outlook continues to be constrained by weak financial fundamentals. The company reported no revenue during 2024 and continues to face persistent losses, negative shareholder equity, increasing debt levels and ongoing cash outflows.

Technical indicators also remain under pressure, with the shares trading below major moving averages and the MACD indicator remaining negative. Valuation metrics provide limited support given the absence of meaningful earnings and dividend data.

More about Ascent Resources

Ascent Resources plc is a London-listed oil and gas company focused primarily on onshore hydrocarbon exploration and production opportunities in the United States. Trading under the ticker AST, the company also manages legacy international investments, including assets connected to ongoing arbitration proceedings relating to its former operations in Slovenia.

Avacta Group’s (LSE:AVCT) oncology division, Avacta Therapeutics, continues to advance its proprietary pre|CISION drug delivery platform, which is designed to activate cancer therapies directly within tumours through Fibroblast Activation Protein (FAP)-mediated targeting. The approach aims to deliver highly potent chemotherapy agents more selectively to tumour tissue while reducing systemic side effects commonly associated with conventional antibody-drug conjugates (ADCs).

The company’s lead programme, AVA6000, has already demonstrated early signs of activity in selected solid tumour indications.

Comparative data positions platform against leading ADC therapies

During its 2026 Science Day event in London, Avacta presented new comparative data from its AVA6103 and AVA6207 programmes, highlighting the potential competitive advantages of the pre|CISION platform against established marketed ADCs.

According to the company, AVA6103 demonstrated significantly faster tumour penetration, higher concentrations of therapeutic payload within tumours and a tumour selectivity index at least three times greater than both Enhertu and Datroway.

Meanwhile, AVA6207’s dual-payload design produced deeper and more sustained responses than single-payload ADCs, including Enhertu, in gastric cancer and FAP-driven tumour models.

Intellectual property and differentiation strategy strengthened

The new data is expected to reinforce Avacta’s differentiation strategy within the rapidly growing oncology drug conjugate market. Management believes the platform’s tumour-selective activation technology could offer advantages in efficacy, tolerability and dosing flexibility compared with traditional ADC approaches.

The findings may also strengthen the company’s intellectual property position as it continues development across multiple oncology programmes.

Financial and partnership risks remain a concern

Despite scientific and clinical progress, Avacta’s broader outlook continues to be constrained by weak financial performance and bearish technical indicators.

The company remains loss-making and continues to face funding pressures, while the absence of major commercial partnerships is viewed as an additional risk factor. Valuation metrics also remain unattractive due to negative earnings and the lack of a dividend.

More about Avacta Group plc

Avacta Group plc is a clinical-stage biotechnology company focused on oncology through its Avacta Therapeutics division. The company develops cancer therapies using its proprietary pre|CISION platform, a FAP-activated drug delivery system designed to concentrate highly potent chemotherapies within the tumour microenvironment while limiting damage to healthy tissue. Its peptide drug conjugates represent a novel class of targeted therapies, with lead candidate AVA6000 focused on doxorubicin-sensitive solid tumours.

Ramsdens Holdings (LSE:RFX) has upgraded its profit guidance for the financial year ending 30 September 2026 following a strong first-half performance. The company now expects profit before tax to reach at least £28.5 million and potentially as high as £31.5 million, well above previous market expectations of £24.1 million.

Trading momentum has been supported by exceptionally strong gold prices, which have increased activity within the group’s precious metals purchasing operations. Jewellery retail sales also remained robust, while pawnbroking loan demand continued to perform strongly.

Diversified operations continue to support growth

Alongside gains in precious metals and lending, Ramsdens reported solid trading within its foreign currency division. The group is continuing to expand its store network despite acknowledging that geopolitical uncertainty, broader economic conditions and travel-related risks could affect future foreign exchange volumes.

Management said the diversified nature of the business continues to provide resilience across varying market conditions.

Strong momentum tempered by cash flow volatility

The company’s outlook is underpinned by improving profitability and strong operational growth. However, investors remain cautious over inconsistent cash conversion and fluctuations in free cash flow generation.

Technical indicators remain supportive, with the shares continuing to trade in a strong upward trend, although some overbought signals suggest the potential for short-term pullbacks.

Valuation remains reasonable despite sector risks

Ramsdens’ valuation is viewed as relatively balanced, supported by a modest dividend yield and stronger earnings guidance for FY26. Management’s positive outlook has added confidence, although the company also highlighted ongoing risks linked to gold price movements and inflationary cost pressures.

More about Ramsdens Holdings

Ramsdens Holdings is a UK-based financial services and retail group specialising in foreign currency exchange, pawnbroking loans, precious metals trading and jewellery retail. Headquartered in Teesside, the FCA-authorised company operates from 175 stores across the UK, including one franchise location, alongside an expanding online platform. The business does not provide unsecured high-cost short-term lending products.

Renishaw (LSE:RSW) reported record revenue of £571.6 million for the nine months ended 31 March 2026, representing growth of 9.5% at actual exchange rates and 13.5% at constant currency. The performance was fuelled by strong demand from semiconductor and electronics manufacturing customers, alongside continued momentum in the aerospace and defence sectors.

Growth was recorded across the company’s industrial metrology, position measurement and specialised technology divisions, with particularly strong expansion in encoder systems and metal additive manufacturing equipment. The group also reported a substantially higher order book.

Third-quarter trading accelerates across key regions

The third quarter marked the strongest quarterly performance in Renishaw’s history, with revenue increasing 14% to £206 million. Order intake strengthened further across the Asia-Pacific region and the Americas, while the EMEA division returned to growth after a slower start earlier in the financial year.

Management said demand trends remain favourable despite ongoing supply chain constraints affecting semiconductor markets and increased logistics costs linked to Middle East tensions and changes to U.S. tariffs.

Full-year guidance maintained after recent upgrade

Despite external cost pressures, Renishaw stated that it does not expect a material impact on operations and reaffirmed its upgraded full-year guidance. The company continues to forecast annual revenue between £775 million and £805 million, alongside adjusted profit before tax in the range of £145 million to £165 million.

The outlook is supported by low leverage, improving earnings expectations and ongoing cost-saving measures, while technical indicators have also shown signs of strengthening.

Valuation and margin pressures temper positive outlook

Although the company’s financial position remains strong, recent margin compression continues to weigh slightly on the broader investment case. In addition, the shares trade on a relatively elevated price-to-earnings multiple, while the dividend yield remains modest.

Even so, strong end-market demand and continued operational momentum continue to support confidence in the group’s long-term positioning.

More about Renishaw

Renishaw is a UK-based engineering and technology company specialising in high-precision measurement and manufacturing systems. Its products provide accuracy, traceability and process control across industrial applications including semiconductors, electronics, aerospace, defence, medical devices and consumer technology markets. The company operates globally across APAC, EMEA and the Americas.

ECR Minerals (LSE:ECR) has issued 25,863,779 new ordinary shares at 0.26 pence each as partial settlement for accrued fees owed to directors, consultants and professional advisers. Chairman Nick Tulloch and three non-executive directors accepted shares in place of cash remuneration relating to the first quarter of 2026.

The company also granted options over 2,952,061 shares to non-executive director Chris Gibbs in exchange for consultancy services.

Following admission of the new shares to AIM trading, ECR’s total issued share capital will increase to 3,316,751,795 ordinary shares, resulting in modest dilution for existing shareholders.

Board increases equity exposure to Australian gold portfolio

After the latest allotment, ECR directors will collectively own just over 4.6% of the enlarged share capital. The additional option awards further increase board exposure to potential upside from the company’s Australian gold exploration assets.

Management’s continued use of equity-based compensation reflects its strategy of preserving cash resources while advancing exploration and development activities across its projects in Victoria and Queensland.

Investors likely to focus on funding discipline and governance

The move highlights ECR’s ongoing efforts to manage funding carefully as it progresses multiple exploration programmes. Investors are likely to monitor the company’s approach to capital discipline, governance and future financing requirements as development work continues.

The company’s financial outlook remains constrained by the absence of revenue, continuing losses and ongoing cash burn, although these pressures are partially offset by a debt-free balance sheet and some improvement in losses and cash flow trends.

Weak valuation and mixed technical indicators remain a challenge

Technical indicators remain neutral to weak, with the shares trading below shorter-term moving averages and the MACD indicator remaining negative.

Valuation metrics also continue to offer limited support due to the company’s negative price-to-earnings ratio and the lack of dividend payments.

More about ECR Minerals

ECR Minerals is a UK-listed mineral exploration and development company focused primarily on gold assets in Australia. Through its wholly owned subsidiaries, the company holds interests in the Bailieston, Creswick and Tambo gold projects in Victoria, alongside alluvial and hard-rock gold projects at Raglan, Blue Mountain and Lolworth Range in Queensland. The group also maintains additional licence applications and unutilised tax losses within Australia.